CURRICULUM VITAE
Mark H. Tuszynski, M.D., Ph.D.
Professional address:
Department of Neurosciences-0626
University of California-San Diego
La Jolla, CA. 92093
Telephone:
FAX:
(858) 534-8857
(858) 534-5220
EDUCATION AND PROFESSIONAL EXPERIENCE:
Bachelor of Science:
University of Minnesota
1975 - 1979
Doctor of Medicine:
University of Minnesota
1979 - 1983
Internship:
(Internal Medicine)
University of Connecticut
1983 - 1984
Neurology Residency:
Cornell University/
The New York Hospital
1984 - 1987
Doctor of Philosophy:
University of California,
San Diego
1991
Assistant Professor
of Neurosciences
University of California,
San Diego
1991 - 1996
Associate Professor
of Neurosciences
University of California,
San Diego
1996 - 2002
Professor of Neurosciences University of California,
San Diego
2002 - present
Vice-Chair, Department
of Neurosciences
University of California,
San Diego
2004 - 2013
Director, Translational
Neuroscience Institute
University of California,
San Diego
2009 - present
AWARDS:
Presidential Scholar, University of Minnesota
Tau Beta Pi Honorary Society
Wasie Foundation Scholar
Silvio O. Conte Research Award, American Academy of Neurology
1
1975
1977
1980
1995
Elected to American Neurological Association
Fellow, American Society for Neural Transplantation and Repair
Sanberg Memorial Award for Brain Repair
Ariens Kappers Medal, Netherlands Institute for Brain Research
National Paralysis Foundation, Spinal Cord Injury Research Award
Barbara Haugh Alzheimer’s Disease Research Award
Visionary Award, Glenner Alzheimer’s Association of San Diego
Heiner Sell Memorial Lectureship, American Spinal Injury Association
Ted Bullock Award, UCSD Neuroscience Program
Adelson Award, American Society for Neurorehabilitation
Goldberg Award Lecture, University of Rochester
Zenith Award, Alzheimer’s Association
Elected to The Dana Alliance for Brain Initiatives
Elected Fellow, American Neurological Association
Jacoby Award, American Neurological Association
Reeve-Irvine Medal
1998
1998
2000
2001
2001
2002
2004
2008
2008
2008
2011
2012
2012
2013
2013
2015
MEDICAL LICENSURE:
California, G056665
SPECIALTY BOARDS:
Board certification in Neurology, 1989.
ACADEMIC SOCIETIES:
Society for Neuroscience
American Academy of Neurology
American Neurological Association
American Medical Association
International Brain Research Organization
American Society for Neural Transplantation
American Society for Experimental NeuroTherapeutics
EDITORIAL, SCIENTIFIC ADVISORY and PROFESSIONAL BOARDS:
Editorial Boards: Lancet Neurology (2001 – 2005), Experimental Neurology (1997-present),
Frontiers in Bioscience (1997-present), Neurobiology of Disease (2000-present),
Neurorehabilitation and Neural Repair (2005 – 2012), Journal of Neurotrauama (2009-present),
Neurological Disease and Therapy section, Marcel-Dekker publications (2000–2006).
Scientific Advisory Boards: The Paralysis Project (1997-2005); Comitato Promotore Telethon
(European Neurological disorder charity) (1997-2006); The Christopher and Dana Reeve
Paralysis Foundation (1999-2007); Canadian and American Spinal Research Organizations
(2000-present); Alzheimer’s Association (2006-present).
Science Committee, American Academy of Neurology (2012 – present)
Program Committee, American Society for Neural Transplantation (1996-1998; Chair, 1999)
Councilor, American Society for Neural Transplantation & Repair (1999-2004)
2
Executive Committee Member, Neural Repair and Rehabilitation Section of American
Neurological Association (ANA) (2000-2006)
Chair, Basic Research Subcommittee, Neural Repair and Rehabilitation Committee of American
Neurological Association (2000-2004)
Faculty of 1000 Review Board (2005–2010)
Medical Advisory Board, George G. Glenner Alzheimer's Family Centers (2002 – present)
Vice-Chair, Clinical Practice Committee, American Society for Neural Transplantation & Repair
(2002-2004)
Secretary, American Society for Neural Transplantation & Repair (2003-2004)
Public Information Committee, Society for Neuroscience (2005-2008)
Member, Center for Ethics and Technology (2005-present)
Medical Advisory Board, San Diego Alzheimer’s Association (2007-present)
Chair, Neural and Ocular Committee, American Society for Gene Therapy (2011-2012)
Member, Science Committee, American Academy of Neurology (2013-2014)
BIOGRAPHICAL INFORMATION:
Birthplace: Halifax, Canada.
Citizenship: U.S., Canadian
High School: Advanced placement two years.
PUBLICATIONS:
ORIGINAL PAPERS:
1. Tuszynski MH, Petito CP. Thalamic aphasia with pathological confirmation. Neurology,
1988; 38:800-802.
2. Rosenberg MB, Friedmann T, Robertson RC, Tuszynski M, Wolff JA, Breakfield XO, Gage
FH. Grafting of genetically modified cells to the damaged brain: Restorative effects of NGF
expression. Science, 1988; 242:1575-1578.
3. Tuszynski MH, Petito CK, Levy DE. Risk factors and clinical manifestations of
pathologically-verified lacunar infarctions. Stroke 1989; 20:990-999.
4. Tuszynski MH, Buzsaki G, Gage FH. NGF enhances graft-induced functional cholinergic
reinnervation of the deafferented hippocampal formation. Neuroscience, 1990; 36:33-44.
5. Tuszynski MH, Armstrong D, Gage FH. Basal forebrain cell death following fimbria-fornix
transection. Brain Res, 1990; 508:241-248.
6. Barnett J, Baecker P, Routledge-Ward C, Bursztyn-Pettegrew H, Chow J, Nguyen B, Bach
C, Chan H, Tuszynski MH, Yoshida K, Rubalcava R, Gage FH. Human beta nerve growth
factor obtained from a baculovirus expression system has potent in vitro and in vivo
neurotrophic activity. Exp Neurol, 1990; 110:11-24.
7. Tuszynski MH, U H.-S., Amaral DG, Gage FH. Nerve growth factor infusion in primate
brain reduces lesion-induced cholinergic neuronal degeneration. Journal of Neuroscience,
1990; 10:3604-3614.
3
8. Tuszynski MH, Gage FH. Potential use of neurotrophic agents in the treatment of
neurodegenerative disorders. Acta Neurobiologica Exp. 1990; 50.
9. Tuszynski MH, U H.-S., Yoshida K, Gage FH. Recombinant human nerve growth factor
infusions prevent cholinergic neuronal degeneration in the adult primate brain. Ann Neurol,
1991; 30:625-636.
10. Hainline B, Tuszynski MH, Posner JB. Ataxia in epidural spinal cord compression.
Neurology, 1992; 42:2193-2195.
11. Tuszynski MH, Peterson D, Ray J, Baird A, Nakahara Y, Gage FH. Fibroblasts genetically
modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the
spinal cord. Exp Neurol, 1994; 126:1-14.
12. Tuszynski MH, Senut MC, Ray J, Roberts J, U H.-S., Gage FH. Somatic gene transfer to
the adult primate CNS: In vitro and In vivo characterization of cells genetically modified to
secrete nerve growth factor. Neurobiol Dis, 1994; 1:67-78.
13. Tuszynski, MH and Gage, FH. Transient NGF infusions combined with fetal bridging
grafts promote long-term cholinergic neuronal rescue and partial functional recovery in the
CNS. Proc Nat Acad Sci, 1995; 92:4621-4625.
14. Tuszynski MH and Gage, FH. Restoring the adult neuronal phenotype: Effects of
neurotrophic factors and axonal growth substrates. Molec Neurobiol, 1995; 10:151-167.
15. Senut MC, Tuszynski MH, Suhr S, Raymon H, Gage FH. Autologous grafts of cells
genetically modified to express human NT-3: Regional differences in responsiveness to the
adult brain and spinal cord. Exp Neurol, 1995; 135:36-55.
16. Tuszynski MH, Roberts J, Senut MC, U H.-S., Gage FH. Gene therapy in the adult
primate brain: Intraparenchymal grafts of cells genetically modified to produce nerve growth
factor prevent cholinergic neuronal degeneration. Gene Therapy, 1996;3:305-314.
17. Tuszynski MH, Gabriel K, Gage FH, Suhr S, Rosetti A, Meyer S. Nerve growth factor
delivery by gene transfer induces differential outgrowth of sensory, motor and noradrenergic
neruties after adult spinal cord injury. Exp Neurol, 1996;137:157-173.
18. Nakahara Y, Senut M-C, Gage FH, Tuszynski MH. Grafts of fibroblasts genetically
modified to secrete NGF, BDNF, NT-3 or basic FGF elicit differential responses in the adult
spinal cord. Cell Transpl, 1996;5:191-204.
19. Tuszynski MH, Mafong E, Meyer S. Central infusions of brain-derived neurotrophic factor
and neurotrophin-4/5, but not nerve growth factor and neurotrophin-3, prevent loss of the
cholinergic phenotype in injured adult motor neurons. Neuroscience, 1996;71:761-771.
20. Thal LJ, Carta A, Clarke WR, Ferris SH, Friedland RP, Petersen RB, Pettegrew JW,
Pfeiffer E, Raskind MA, Sano M, Tuszynski MH, Woolson RF. A one-year multicenter placebocontrolled trial of Acetyl-L-carnitine in patients with Alzheimer's disease. Neurology,
1996;47:705-711.
4
21. Winkler J, Ramirez GA, Kuhn H, Peterson DA, Tuszynski MH, Gage FH, Thal LJ.
Reversible induction of Schwann cell hyperplasia and sprouting of sensory and sympathetic
neurites in vivo after continuous intracerebroventricular administration of nerve growth factor.
Ann Neurol, 1996;40:128-139.
22. Tuszynski MH, Murai K, Blesch A, Grill R, Miller I. Functional characterization of NGFsecreting cell grafts to the acutely injured spinal cord. Cell Transpl, 1997;6:361-368.
23. Eberling JL, Roberts JA, Rapp PR, Tuszynski MH, Jagust WJ. Glucose cerebral
metabolism and memory in aged rhesus macaques. Neurobiol Aging, 1997;18:437-443.
24. Tuszynski MH. Neuronal loss and Alzheimer's disease: Potential effects of neurotrophic
factors. Whitehouse, P., ed. Proceedings of the ANA Conference on Alzheimer's Disease,
University of Virginia Press, 1997.
25. Grill R, Blesch A, Tuszynski MH. Robust growth of chronically injured spinal cord axons
induced by grafts of genetically modified NGF-secreting cells. Exp Neurol, 1997;148:444-452.
26. Grill R, Murai K, Blesch A, Gage FH, Tuszynski MH. Cellular delivery of neurotrophin-3
promotes corticospinal axonal growth and partial functional recovery after spinal cord injury.
Journal of Neuroscience, 1997;17:5560-5572.
27. Tuszynski M, Weidner N, McCormack M, Miller I, Powell H, Conner J. Grafts of
genetically modified Schwann cells to the spinal cord: Survival, axon growth and myelination.
Cell Transpl, 1998;7:187-196.
28. Tuszynski MH, Smith DE, Roberts J, McKay H, Mufson E. Targeted intraparenchymal
delivery of human NGF by gene transfer to the primate basal forebrain for 3 months does not
accelerate ß-amyloid plaque deposition. Exp Neurol, 1998;154:573-582.
29. Blurton-Jones MM, Roberts J, Tuszynski MH. Estrogen receptor immunoreactivity in the
adult primate brain: neuronal distribution and association with p75, trk A, and choline
acetyltransferase. J Comp Neurol, 1999;405:529-542.
30. Blesch A, Uy HS, Grill RJ, Cheng JG, Patterson PH, Tuszynski MH. LIF augments
neurotrophin expression and corticospinal axon growth after adult CNS injury.
Journal of Neuroscience, 1999;19: 3556-3566.
31. Tuszynski MH, Gabriel K, Gerhardt K, Szollar S. The human spinal cord retains
substantial structural mass in chronic stages after injury. J Neurotrauma, 1999;16:523-531.
32. Weidner N, Blesch A, Grill R, Tuszynski MH. NGF-hypersecreting Schwann cell grafts
augment and guide spinal cord axonal growth, and remyelinate CNS axons in a phenotypically
appropriate manner that correlates with expression of L1. J Comp Neurol, 1999;413:495-506.
33. Weidner N, Grill RJ, Tuszynski MH. Elimination of basal lamina and the collagen “scar”
after spinal cord injury fails to augment corticospinal tract regeneration. Exp Neurol,
1999;160:40-50.
5
34. Smith DE, Roberts J, Gage FH, Tuszynski MH. Age-associated neuronal atrophy occurs
in the primate brain and is reversible by growth factor gene therapy. Proc Nat Acad Sci,
1999;96:10893-10898.
35. Blesch A, Uy HS, Diergardt N, Tuszynski MH. Neurite outgrowth can be modulated in vitro
using a tetracycline-repressible gene therapy vector expressing human nerve growth factor.
J Neurosci Res, 2000;59:402-409.
36. Merrill DA, Roberts JA, Tuszynski MH. Conservation of neuron number and size in
entorhinal cortex layers II, III and V/VI of aged primates. J Comp Neurol, 2000;422:396-401.
37. Bowes M, Tuszynski MH, Conner J, Zivin JA. Continuous intrathecal fluid infusions
elevate NGF levels and prevent functional deficits after spinal cord ischemia. Brain Res, 2000:
883:178-183.
38. Tuszynski MH. Intraparenchymal NGF infusions rescue degenerating cholinergic
neurons. Cell Transpl, 2000; 9:629-636.
39. Blurton-Jones MM, Tuszynski MH. Reactive astrocytes express estrogen receptors
in the injured primate brain. J Comp Neurol, 2001; 433:115-123.
40. Lu P, Blesch A, Tuszynski MH. Neurotrophism without neurotropism: BDNF promotes
survival but not growth of lesioned corticospinal neurons. J Comp Neurol, 2001;436:456-470.
41. Conner JM, Darracq MA, Roberts J, Tuszynski MH. Non-tropic actions of neurotrophins:
Subcortical NGF gene delivery reverses age-related degeneration of primate cortical cholinergic
innervation. Proc Nat Acad Sci, 2001; 98:1941-1946.
42. Weidner N, Ner A, Salimi N, Tuszynski MH. Spontaneous corticospinal axonal plasticity
and functional recovery after adult CNS injury. Proc Nat Acad Sci, 2001; 98:3513-3518.
43. Blesch A, Tuszynski MH. GDNF gene delivery to injured adult CNS motor neurons
promotes axonal growth, expression of the trophic neuropeptide CGRP and cellular protection.
J Comp Neurol, 2001;436:399-410.
44. Blesch A, Conner JM, Tuszynski MH. Modulation of neuronal survival and axonal growth
in vivo by tetracycline-regulated neurotrophin expression. Gene Therapy, 2001;8:954-960.
45. Jones LL, Tuszynski MH. Chronic intrathecal infusions after spinal cord injury cause
scarring and compression. Microscopy Res Tech, 2001;54:317-324.
46. Merrill DA, Chiba AA, Tuszynski MH. Conservation of neuronal number and size in the
entorhinal cortex of behaviorally characterized aged rats. J Comp Neurol, 2001; 438:445-456.
47. Jones LL, Yamaguchi Y, Stallcup WB, Tuszynski MH. NG2 is a major chondroitin sulfate
proteoglycan produced after spinal cord injury and is secreted by macrophages and
oligodendrocyte progenitors. Journal of Neuroscience, 2002, 22:2792-2803.
48. Tuszynski MH, Grill R, Jones LL, McKay HM, Blesch A. Spontaneous and augmented
growth of axons in the primate spinal cord: Effects of local injury and NGF-secreting cell grafts.
J Comp Neurol, 2002; 449:88-101.
6
49. Jones LL, Tuszynski MH. Spinal cord injury elicits expression of keratan sulfate
proteoglycans by oligodendrocyte progenitors, reactive microglia and macrophages.
Journal of Neuroscience, 2002, 22:4611-4624.
50. Blurton-Jones M, Tuszynski MH. Estrogen receptor-beta co-localizes extensively with
parvalbumin-labeled inhibitory neurons in the cortex, amygdala, basal forebrain, and
hippocampal formation of intact and ovariectomized adult rats. J Comp Neurol, 2002; 438:445456.
51. Lacroix S, Chang L, Rose-John S, Tuszynski MH. Delivery of hyper-interleukin-6 to the
injured spinal cord increases neutrophil and macrophage infiltration and inhibits axonal growth.
J Comp Neurol, 2002;454:213-228.
52. Lu P, Jones LL, Snyder EY, Tuszynski MH. Neural stem cells constitutively secrete
neurotrophic factors and promote robust host axonal growth after spinal cord injury. Exp
Neurol, 2003;181:115-129.
53. Merrill DA, Karim R, Darraq M, Chiba AA, Tuszynski MH. Hippocampal neurogenesis does
not correlate with spatial learning in aged rats. J Comp Neurol, 2003; 459:201-207.
54. Tuszynski MH, Grill RJ, Jones LL, Brant A, Blesch A, Löw K, Lacroix S, Lu P. NT-3 gene
delivery elicits growth of chronically injured corticospinal axons and modestly improves
functional deficits after chronic scar resection. Exp Neurol, 2003; 181:47-56.
55. Jones LL, Margolis RU, Tuszynski MH. The chondroitin sulfate proteoglycans neurocan,
brevican, phosphocan and versican are differentially regulated following spinal cord injury. Exp
Neurol, 2003;189:392-411.
56. Conner JM, Culberson A, Packowski C, Chiba A, Tuszynski MH. Lesions of the basal
forebrain cholinergic system impair task acquisition and abolish cortical plasticity associated
with motor skill learning. Neuron, 2003, 38:819-829.
57. Blesch A, Tuszynski MH. Cellular GDNF gene delivery promotes growth of motor and
dorsal column sensory axons after partial and complete spinal cord transactions and induces
remyelination . J Comp Neurol, 2003; 4467:403-417.
58. Tobias CA, Shumsky JS, Shibata M, Tuszynski MH, Fischer I, Tessler A, Murray M.
Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates
sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy and
provides limited regeneration. Exp Neurol, 2003;184:97-113.
59. Blurton-Jones M, Kuan PN, Tuszynski MH. Anatomical evidence for trans-synaptic
influences of estrogen on BDNF expression. J Comp Neurol, 2003;468:346-360.
60. Jones LL, Sajed D, Tuszynski MH. Axonal regeneration through regions of CSPG
deposition after spinal cord injury: A balance of permissiveness and inhibition.
Journal of Neuroscience, 2003;23:9276-9288.
61. Lacroix S, Havton L, McKay H, Yang H, Brant A, Roberts J, Tuszynski MH. Bilateral
corticospinal projections from unilateral motor areas in macaque monkeys: a quantitative study.
J Comp Neurol, 2004;473:147-161.
7
62. Stokols S, Tuszynski MH. The fabrication and characterization of linearly oriented nerve
guidance scaffolds for spinal cord injury. Biomaterials, 2004;25:5839-5846.
63. Smith DE, Rapp PR, McKay HM, Roberts JA, Tuszynski MH. Memory impairment in aged
primates is associated with focal death of cortical neurons and atrophy of subcortical neurons.
Journal of Neuroscience, 2004;24:4373-4381.
64. Lu P, Yang H, Jones LL, Filbin MT, Tuszynski MH. Combinatorial therapy with
neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury.
Journal of Neuroscience, 2004; 24:6402-6409.
65. Lu P, Blesch A, Tuszynski MH. Induction of bone marrow stromal cells to neurons:
differentiation, transdifferentiation, or artifact? J Neurosci Res, 2004; 77:174-191.
66. Steeves J, Fawcett J, Tuszynski MH. Report of international clinical trials workshop on
spinal cord injury. Spinal Cord, 2004;42:591-597
67. Lu P, Jones LL, Tuszynski MH. BDNF-expressing marrow stromal cells support extensive
axonal growth at sites of spinal cord injury. Exp Neurol, 2005 191:344-60.
68. Blesch A, Pfeiffer A, Conner JM, Britton W, Verma I, Tuszynski MH. Regulated
lentiviral NGF gene transfer controls rescue of medial septal cholinergic neurons. Molec Ther,
2005;11:916-925.
69. Conner JM, Chiba AA, Tuszynski MH. The basal forebrain cholinergic system is essential
for cortical plasticity and functional recovery following brain injury. Neuron, 2005, 46:173-9.
70. Courtine G, Roy RR. Hodgson J, McKay HM, Zhong H, Yang H, Tuszynski MH,
Edgerton VR. Kinematic and EMG determinants in quadrupedal locomotion of a non-human
primate. J Neurophysiol, 2005, 93:3127-3145.
71. Spinal Cord Translational Study Group (Tuszynski MH, corresponding author).
Recommended guidelines for studies of human subjects with spinal cord injury. Spinal Cord,
2005, 43:453-458.
72. Tuszynski MH, Thal L, Pay M, Salmon DP, U H-S, Bakay R, Patel P, Blesch A, Vahlsing
HL, Ho G, Tong G, Potkin SG, Fallon J, Hansen L, Mufson EJ, Kordower JH, Gall C, Conner
JM. A phase I clinical trial of nerve growth factor gene therapy for Alzheimer’s disease. Nature
Medicine, 2005, 11:551-555.
73. Courtine G, Roy RR, Hodgson J, McKay H, Yang H, Zhong H, Tuszynski MH, Edgerton R.
Performance of locomotion and foot grasping following a unilateral thoracic corticospinal tract
lesion in monkeys (Macaca Mulatta). Brain, 2005;128:2338-2358.
74. Stokols S, Tuszynski MH. Freeze-dried agarose scaffolds with uniaxial channels stimulate
and guide linear axonal regeneration following spinal cord injury. Biomaterials, 2006;27:443-51
75. Yang H, Lu P, McKay HM, Bernot T, Keirstead H, Steward O, Gage FH, Edgerton ER,
Tuszynski MH. Endogenous neurogenesis replaces oligodendrocytes and astrocytes after
primate spinal cord injury. J Neurosci, 2006;26:2157-2166
8
76. Stokols S, Sakamoto J, Breckon C, Holt T, Weiss J, Tuszynski MH. Templated agarose
scaffolds support linear axonal regeneration. Tissue Engineering, 2006; 12:2777-2787.
77. Blurton-Jones M, Tuszynski MH. Estradiol-induced modulation of estrogen receptor-ß and
GABA within the adult neocortex: A potential trans-synaptic mechanism for estrogen modulation
of BDNF. J Comp Neurol, 2006, 499:603-12.
78. Ramanathan D, Conner JM, Tuszynski MH. A form of motor cortical plasticity that
correlates with recovery of function after brain injury. Proc Natl Acad Sci, 2006;103 30:1137011375.
79. Taylor L, Jones LL, Tuszynski MH, Blesch A. NT-3 gradients established by lentiviral
gene delivery promote short-distance axonal bridging beyond cellular grafts in the injured spinal
cord. Journal of Neuroscience, 2006; 26:9713-9721.
80. Tuszynski MH. Challenges to the report of nogo antibody effects in primates. Nature
Medicine 2006, 12:1231-1232 (letter)
81. Lu P, Yang H, Culbertson M, Graham L, Roskams AJ, Tuszynski MH. Olfactory
ensheathing cells do not exhibit unique migratory or axonal growth-promoting properties after
spinal cord injury. Journal of Neuroscience, 2006: 26:11120-11130.
82. Fawcett JW, Curt A, Steeves JD, Coleman WP, Tuszynski MH, et al. Guidelines for the
conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous
recovery after spinal cord injury and statistical power needed for therapeutic clinical trials.
Spinal Cord, 2007; 45:190-205.
83. Steeves JD, Lammertse D, Curt A, Fawcett JW, Tuszynski MH, et al. Guidelines for the
conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial
outcome measures. Spinal Cord, 2007; 45:206-221.
84. Tuszynski MH, Steeves JD, Fawcett JW, Lammertse D, et al. Guidelines for the conduct
of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial
inclusion/exclusion criteria and ethics. Spinal Cord, 2007; 45:222-231.
85. Lammertse D, Tuszynski MH, Steeves JD, Curt A, Fawcett JW, et al. Guidelines for the
conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial
design. Spinal Cord, 2007; 45:232-242.
86. Lu P, Jones LL, Tuszynski MH. Axon regeneration through scars and into sites of chronic
spinal cord injury. Exp Neurol, 2007; 203:8-21.
87. Herzog CD, Dass B, Holden JE, Stansell J, Gasmi M, Tuszynski MH, Bartus RT, Kordower
JH. Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity
of the dopaminergic nigrostriatal system in aged monkeys. Movement Disorders 2007; 22:11241132.
88. Tuszynski MH. Rebuilding the brain: resurgence of fetal grafting. Nature Neuroscience,
News and Views. 2007; 10:1-2.
9
89. Blesch A, Tuszynski MH. Transient growth factor delivery sustains regenerated axons
after spinal cord injury. Journal of Neuroscience, 2007; 27:10535-10545.
90. Bishop KM, Hofer EK, Mehta A, Ramirez A, Sun L, Tuszynski MH, Bartus RT. Therapeutic
potential of CERE-110 (AAV2-NGF): Targeted, stable, and sustained NGF delivery and trophic
activity on rodent basal forebrain cholinergic neurons. Exp Neurol 2008; 211:574-584.
91. Hollis ER, Kadoya K, Samulski RJ, Tuszynski MH. Efficient retrograde neuronal
transduction utilizing self-complementary AAV1. Molec Ther, 2008; 16:296-301.
92. Herzog CD, Dass B, Gasmi M, Bakay R, Stansell JE, Tuszynski MH, Bankiewicz K, Chen
EY, Chu Y, Bishop K, Kordower JH, Bartus RT. Transgene expression, bioactivity, and safety of
CERE-120 (AAV2-neurturin) following delivery to the monkey striatum. Mol Ther. 2008,
16:1737-1744
93. Löw K, Culbertson M, Bradke F, Tessier-Lavigne M, Tuszynski MH. Netrin-1 is a novel
myelin-associated inhibitor to axon growth. Journal of Neuroscience, 2008, 28:1099-1108.
94. Nagahara A, Bernot T, Tuszynski MH. Age-related cognitive deficits in rhesus monkeys
mirror human deficits on an automated test batters. Neurobiol Aging, 2010; 31:1020-1031.
95. Nagahara A, Bernot T, Moseanko R, Blesch A, Conner JM, Ramirez A, Gasmi M,
Tuszynski MH. Long-term reversal of cholinergic neuronal decline in aged non-human
primates by lentiviral NGF gene delivery. Exp Neurol, 2009, 215:153-159.
96. Mehrotra S, Lynam D, Maloney R, Pawelec KM, Tuszynski MH, Lee I, Chan C, Sakamoto
J. Time controlled protein release from layer-by-layer assembled multilayers functionalized
agarose hydrogels. Advanced Functional Materials. 2010, 20:247-258.
97. Rosenzweig E, Brock JH, Culbertson MD, Lu P, Moseanko R, Edgerton VR, Havton LA,
Tuszynski MH. Extensive spinal decussation and bilateral termination of cervical corticospinal
projections in Rhesus monkeys. J Comp Neurol, 2009, 513:151-163.
98. Hollis ER, Lu P, Blesch A, Tuszynski MH. IGF-I gene delivery promotes corticospinal
neuronal survival but not regeneration after adult CNS injury, Exp Neurol, 2009, 215:53-59.
99. Ramanathan D, Tuszynski MH, Conner JM. The basal forebrain cholinergic system is
required specifically for behaviorally-mediated cortical map plasticity. J Neurosci, 2009,
29:5992-6000.
100. Hollis ER, Jamshidi P, Low K, Blesch A, Tuszynski MH. Induction of corticospinal
regeneration by lentiviral trkB-Induced Erk activation, Proc Nat Acad Sci, 2009, 106:7215-7220.
101. Nagahara A, Merrill DA, Coppola G, Tsukada S, Schroder BE, Shaked GM, Wang L,
Blesch A, Kim A, Conner JC, Rockenstein E, Chao MV, Koo E, Geschwind D, Masliah, Chiba
AA, Tuszynski MH. Neuroprotective effects of BDNF in rodent and primate models of
Alzheimer’s disease. Nature Medicine, 2009, 15:31-337.
102. Conner JM, Franks KM, Titterness AK, Russell K, Merrill DA, Christie BR, Sejnowski TJ,
Tuszynski MH. NGF is essential for hippocampal plasticity and learning. J Neurosci, 2009,
29:10883-10889.
10
103. Alto L, Havton LA, Conner JM, Hollis ER, Blesch A, Tuszynski MH. Chemotropic guidance
facilitates axonal regeneration into brainstem targets and synapse formation after spinal cord
injury. Nature Neuroscience, 2009, 12: 1106-1113.
104. Kadoya K, Tsukada S, Lu P, Coppola G, Geschwind D, Flibin M, Blesch A, Tuszynski MH.
Combined intrinsic and extrinsic neuronal mechanisms facilitate bridging axonal regeneration
one year after spinal cord injury. Neuron, 2009, 64: 165-172.
105. Löw K, Blesch A, Herrmann J, Tuszynski MH. A dual promoter lentiviral vector for the in
vivo evaluation of gene therapeutic approaches to axon regeneration after spinal cord injury.
Gene Therapy, 2010, 17:577-591.
106. Conner JM, Kulczycki M, Tuszynski MH. Unique contributions of distinct cholinergic
projections to motor cortical plasticity and learning. Cerebral Cortex, 2010, 20:2739-2748.
107. Gros T, Sakamoto J, Blesch A, Havton L, Tuszynski MH. Regeneration of long-tract
axons through sites of spinal cord injury using templated agarose scaffolds. Biomaterials,
2010, 31:6719-6729.
108. Hollis ER, Jamshidi P, Lorenzana AO, Lee JK, Gray SJ, Samulski RJ, Zheng B,
Tuszynski MH. Transient demyelination increases the efficiency of tetrograde AAV
transduction.
Molec Ther, 2010, 18:1496-500.
109. Brock JH, Rosenzweig ES, Blesch A, Moseanko R, Havton LA, Edgerton VR, Tuszynski
MH. Local and remote growth factor effects after primate spinal cord injury. J Neurosci, 2010,
30:9728-37.
110. Rosenzweig ES, Courtine G, Jindrich DL, Brock JH, Ferguson AR, Strand SC, Nout YS,
Roy RR, Miller DM, Beattie MS, Havton LA, Bresnahan JC, Edgerton VR, Tuszynski M.
Extensive spontaneous plasticity of corticospinal projections after primate spinal cord injury.
Nature Neurosci, 2010, 13:1505-1510.
111. Jindrich DL, Courtine G, Liu J, McKay HL, Moseanko R, Bernot TJ, Roy RR, Zhong H,
Tuszynski MH, Edgerton WR. Unconstrained three-dimensional reaching in Rhesus monkeys.
Exp Brain Res 2011, 209:35-50.
112. Wang L, Conner JM, Rickert JL, Tuszynski MH. Structural plasticity within highly specific
neuronal populations identifies a parcellation of motor learning. Proc Nat Acad Sci, 2011;
108:2545-2550.
113. Merrill DA, Masliah E, Roberts JA, McKay H, Kordower JH, Mufson EJ, Tuszynski MH.
Association of early experience with neurodegeneration in aged primates. Neurobiol Aging,
2011; 32:151-156.
114. Mehrotra S, Lynam D, Liu C, Shahriari D, Lee I, Tuszynski MH, Sakamoto J, Chan C.
Time controlled release of arabinofuranosylcytosine (Ara-C) from agarose hydrogels using
layer-by-layer assembly: an in vitro study. J Biomater Sci Polym Ed. 2012; 23:439-63.
11
115. Lu P, Blesch A, Graham L, Wang W, Samara R, Banos K, Haringer V, Havton L,
Weishaupt M, Bettett D, Fouad K, Tuszynski MH. Motor axonal regeneration after partial and
complete spinal cord transection. J Neurosci, 2012, 13:8208-8218.
116. Blesch A, Lu P, Tsukada S, Alto LT, Roet K, Coppola G, Geschwind D, Tuszynski MH.
Conditioning lesions before or after spinal cord injury recruit broad genetic mechanisms that
sustain axonal regeneration: superiority to cAMP-mediated effects. Exp Neurol 2012;235:16273.
117. Nout YS, Ferguson AR, Strand SC, Moseanko R, Hawbecker S, Zdunowski S, Nielson JL,
Roy RR, Zhong H, Rosenzweig ES, Brock JH, Courtine G, Edgerton VR, Tuszynski MH,
Beattie MS, Bresnahan JC. Methods for functional assessment after c7 spinal cord hemisection
in the rhesus monkey. Neurorehabil Neural Repair. 2012; 26:556-69.
119. Yoon SO, Park DJ, Ryu JC, Ozer HG, Tep C, Shin YJ, Lim TH, Pastorino L, Kunwar AJ,
Walton JC, Nagahara AH, Lu KP, Nelson RJ, Tuszynski MH, Huang K. JNK3 perpetuates
metabolic stress induced by Aβ peptides. Neuron. 2012; 75:824-37.
119. Tuszynski MH and Steward O. Primer on the study of axonal regeneration. Neuron, 2012;
74:777-791.
120. Lu P, Wang Y, Graham L, McHale K, Gao M, Wu D, Brock J, Blesch A, Rosenzweig ES,
Havton LA, Zheng B, Conner JM, Marsala M, Tuszynski MH. Long-distance growth and
connectivity of neural stem cells after severe spinal cord injury: Cell-intrinsic mechanisms
overcome spinal inhibition. Cell, 2012; 150: 1264-1273.
121. Gao M, Lu P, Bednark B, Lynam D, Conner JM, Sakamoto J, Tuszynski MH. Templated
agarose scaffolds for the support of motor axon regeneration into sites of complete spinal cord
transection. Biomaterials. 2013; 34:1529-36.
122. Ommaya AK, Adams KM, Allman RM, Collins EG, Cooper RA, Dixon CE, Fishman PS,
Henry JA, Kardon R, Kerns RD, Kupersmith J, Lo A, Macko R, McArdle R, McGlinchey RE,
McNeil MR, O'Toole TP, Peckham PH, Tuszynski MH, Waxman SG, Wittenberg GF.
Opportunities in rehabilitation research. J Rehabil Res Dev. 2013;50:7-23.
123. Do JL, Bonni A, Tuszynski MH. SnoN facilitates axonal regeneration after spinal cord
injury. PLOS ONE, 2013, 8(8):e71906.
124. Yoon C, Vanniekerk E, Henry K, Ishikawa T, Orita S, Tuszynski MH, Campana WM. Low
density lipoprotein receptor-related protein 1 (LRP1) dependent cell signaling promotes axonal
regeneration. J Biol Chem, 2013, 288:26557-68.
125. Nagahara AH, Mateling M, Wang L, Eggert S, Rockenstein E, Imracs I, Koo EH, Masliah
E, Tuszynski MH. Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP
transgenic mice. J Neurosci 2013; 33: 15596-15602.
126. Lu P, Wang Y, Graham L, McHale K, Gao M, Wu D, Brock J, Blesch A, Rosenzweig ES,
Havton LA, Zheng B, Conner JM, Marsala M, Tuszynski MH. Neural stem cell dissemination
after grafting to CNS injury sites. Cell 2014; 156: 388-389.
127. Nielson JL, Guandique CF, Liu AW, Burke DA, Lash AT, Moseanko R, Hawbecker A,
12
Strand SC, Zdunowski S, Irvine KA, Brock JH, Nout-Lomas YS, Gensel JC, Anderson KD,
Segal MR, Rosenzweig ED, Magnuson DSK, Whittemore SR, McTigue DM, Popovich PG,
Rabchevsky AG, Scheff SW, Steward O, Courtine G, Edgerton VR, Tuszynski MH, Beattie
MS, Bresnahan JC, Ferguson AR. Development of a database for translational spinal cord
injury research. J Neurotrauma, 2014; 31:1789-99
128. Lemmon VP, Ferguson AR, Popovich PG, Xu XM, Snow DM, Igarashi M, Beattie CE,
Bixby JL; MIASCI Consortium. Minimum information about a spinal cord injury experiment: a
proposed reporting standard for spinal cord injury experiments. J Neurotrauma. 2014; 31:135461.
129. Tuszynski MH, Wang Y, Graham L, McHale K, Gao M, Wu D, Brock J, Blesch A,
Rosenzweig ES, Havton LA, Zheng B, Conner JM, Marsala M, Lu P. Neural stem cells in
models of spinal cord injury. Exp Neurol. 2014;261C:494-500.
130. Biane J, Conner JM, Tuszynski MH. Nerve growth factor is primarily produced by
GABAergic neurons of the adult rat cortex. Front Cell Neurosci. 2014;8:220.
131. Lu P, Graham L, Wang Y, Wu D, Tuszynski M. Promotion of survival and differentiation of
neural stem cells with fibrin and growth factor cocktails after severe spinal cord injury. J Vis
Exp. 2014; 89.
132. Nielson JL, Haefeli J, Salegio EA, Liu AW, Guandique CF, Stück ED, Hawbecker S,
Moseanko R, Strand SC, Zdunowski S, Brock JH, Roy RR, Rosenzweig ES, Nout-Lomas YS,
Courtine G, Havton LA, Steward O, Reggie Edgerton V, Tuszynski MH, Beattie MS, Bresnahan
JC, Ferguson AR. Leveraging biomedical informatics for assessing plasticity and repair in
primate spinal cord injury. Brain Res. 2014 [Epub ahead of print].
133. Biane J, Conner JM, Tuszynski MH. Nerve growth factor is primarily produced by
GABAergic neurons of the adult rat cortex. Front Cell Neurosci. 2014; 8:220.
134. Lu P, Woodruff G, Wang Y, Graham L, Hunt M, Wu D, Boehle E, Ahmad R, Poplawski G,
Brock J, Goldstein LSB, Tuszynski MH. Long-distance axonal growth from human induced
pluripotent stem cells after spinal cord injury. Neuron, 2014; 83:789-96.
135. Nielson JL, Haefeli J, Salegio EA, Liu AW, Guandique CF, Stück ED, Hawbecker S,
Moseanko R, Strand SC, Zdunowski S, Brock JH, Roy RR, Rosenzweig ES, Nout-Lomas YS,
Courtine G, Havton LA, Steward O, Reggie Edgerton V, Tuszynski MH, Beattie MS, Bresnahan
JC, Ferguson AR. Leveraging biomedical informatics for assessing plasticity and repair in
primate spinal cord injury. Brain Res. 2015; 1619:124-138.
136. Shahriari D, Koffler J, Lynam DA, Tuszynski MH, Sakamoto JS. Characterizing the
Degradation of Alginate Hydrogel for Use in Multilumen Scaffolds for Spinal Cord Repair.
J Biomed Mater Res. 2015; in press.
137. Lynam DA, Shahriari D, Wolf KJ, Angart PA, Koffler J, Tuszynski MH, Chan C, Walton P,
Sakamoto J. Brain derived neurotrophic factor release from layer-by-layer coated agarose
nerve guidance scaffolds. Acta Biomater. 2015; 18:128-131.
138. Biane J, Scanziani M, Tuszynski MH, Conner JM. Motor cortex maturation is associated
with reductions in recurrent connectivity among functional subpopulations and increases in
intrinsic excitability. J Neurosci, 2015; 35: 4719-4728.
13
139. Ramanathan DS, Conner JM, Anilkumar AA, Tuszynski MH. Cholinergic systems are
essential for late-stage maturation and refinement of motor cortical circuits. J Neurophysiol.
2015, 113:1585-1597.
140. Brock JH, Graham L, Staufenberg E, Collyer E, Koffler J, Tuszynski MH. Bone Marrow
Stromal Cell Intraspinal Transplants Fail to Improve Motor Outcomes in a Severe Model of
Spinal Cord Injury. J Neurotrauma. 2015, in press.
141. Tuszynski MH, Yang JH, Barba D, U HS, Bakay R, Pay MM, Masliah E, Conner JM,
Kobalka P, Roy S, Nagahara AH. Neuronal responses to nerve growth factor gene therapy
in Alzheimer’s disease. JAMA Neurology 2015; 72:1139-1147.
142. Friedli L, Rosenzweig ES, Barraud Q, Schubert M, Dominici M, Awai L, Nielson JL,
Musienko P, Nout-Lomas Y, Zhong H, Zdunowski S, Roy RR, Strand SC, van den Brand R,
EMSCI Study Group, Havton LA, Beattie MS, Bresnahan JC, Bézard E,, Bloch J, Edgerton
VR, Ferguson AR, Curt A, Tuszynski MH, Courtine G. Pronounced species divergence in
functional recovery after lateralized spinal cord injury: corticospinal tract properties favor
primates. Science Trans Med. 2015; 7:302.
143. Characterizing the Degradation of Alginate Hydrogel for Use in Multilumen Scaffolds for
Spinal Cord Repair. Shahriari D, Koffler J, Lynam DA, Tuszynski MH, Sakamoto JS.
J Biomed Mater Res A. 2015, Epub ahead of print. PMID: 26488452
144. Biane JS, Takashima Y, Conner JM, Massimo Scanziani, Tuszynski MH. Thalamocortical
projections exhibit plasticity onto behaviorally-relevant neurons during adult motor learning.
Neuron 2016, in press.
145. Kadoya K, Paul Lu P, Nguyen K, Lee-Kubli C, Yao L, Poplawski G, Dulin J,
Takashima Y, Biane J, Conner J, Zhang S-C, Tuszynski MH. Robust corticospinal
regeneration enabled by spinal cord reconstitution with homologous neural grafts. Nature
Medicine, in press.
SELECTED CHAPTERS AND REVIEWS:
1. Tuszynski MH, Gage FH. Neural grafting in neurodegenerative diseases. ISI Atlas of
Science, 1988; 2:229-234.
2. Tuszynski MH, Jinnah HA, Gage FH. Delivery of neuroactive compounds to the brain:
Potential utility of genetically-modified cells. Neurobiol Aging, 1989; 10: 644-645.
3. Chen KC, Tuszynski MH, Gage FH. Role of neurotrophic factors in Alzheimer's disease.
Neurobiol Aging, 1989; 10:545-546.
4. Gage FH, Tuszynski MH, Chen K, Armstrong D, Buzsaki G. Survival, growth and function
of damaged cholinergic neurons. Central Cholinergic Synaptic Transmission. Experientia
supplementa, 1989; 57:259-274.
14
5. Gage FH, Fisher LJ, Jinnah H, Rosenberg MB, Tuszynski MH, Rae J, Friedmann T.
Grafting genetically modified cells to the brain: Conceptual and technical issues. Prog Brain
Res, 1990; 82:1-10.
6. Tuszynski MH, Chen K, Gage FH. Neurotrophic factors in the CNS: Possible therapeutic
interventions. In: Proceedings of the Third National Conference on Alzheimer's Disease and
Dementia. Altman HJ, ed. Plenum Press, New York. 1990.
7. Gage FH, Chen KS, Tuszynski MH, Fagan A. Functions of NGF on central cholinergic
neurons. In: Brain Repair. Aguayo AJ, Ottoson D, ed. Macmillan Press, London. 1990.
8. Gage FH, Rosenberg MB, Tuszynski MH, Yoshida K, Armstrong DM, Hayes R, Friedmann
T. Gene therapy in the CNS: Intracerebral grafting of genetically modified cells. Prog Brain Res,
1990; 86:205-217.
9. Gage FH, Tuszynski MH, Chen K, Higgins G. NGF function in the central nervous
system. In: Current Topics in Microbiology and Immunology, Bothwell M, ed. Springer-Verlag,
Berlin. p71-94, 1991.
10. Gage FH, Tuszynski MH, Yoshida K, Higgins G. Nerve growth factor expression and
function in the CNS. In: Growth Factors and Alzheimer's Disease, Hefti F, Brachet P, Will B,
Christen Y, eds. Springer-Verlag, Berlin. p106-116. 1991.
11. Tuszynski MH, Gage FH. In vivo assay of neuron-specific effects of nerve growth factor.
In: Meth Enzymol, 1991; 198:35-47.
12. Gage FH, Tuszynski MH, Chen KS, Fagan AM, Higgins GA. Nerve growth factor function
in the central nervous system. Curr Top Microbiol Immunol, 1991; 165:71-93.
13. Chen KS, Tuszynski MH, Higgins GA, Gage FH. Functional effects of chronic nerve
growth factor infusions on adult and aged basal forebrain cholinergic neurons. In: Khachiturian
ZS and Blass JP, ed. Alzheimer's Disease. New Treatment Strategies. Marcel Dekker, Inc.
New York. p103-124. 1992.
14. Tuszynski MH, Gage FH. Neurotrophic factors and neuronal loss: Potential relevance to
Alzheimer's disease. In: Alzheimer's Disease. Terry R, Katzman R, Bick KL, eds. Raven
Press, New York. 1994. pp.405-418.
15. Tuszynski MH, Gage FH. Neurotrophic factors and diseases of the nervous system. Ann
Neurol, 1994; 35:S9-12.
16. Gage FH, Chalmers GR, Eagle KL, Kawaja MD, Tuszynski MH. Functional recovery
following damage to the adult septohippocampal system. In: Neurobehavioral Plasticity:
Learning, Development and Response to Brain Insults. Spear NE, Sprear LP, Woodruff M
(eds). Lawrence Erlbaum Assoc. Publishers, Trenton 1994.
17. Gage FH, Buzsaki G, Tuszynski MH. Reconstruction of the basal forebrain cholinergic
circuits of the aged and young brain-damaged rat. Current Communications in Molecular
Biology: The Molecular Biology of Alzheimer's Disease. 1995.
15
18. Tuszynski MH, Gage FH. Neuronal Growth and Transplantation in the Adult Central
Nervous System. In: Princples of Medical Biology. Bittar E, Bittar R, ed. JAI press, Inc. New
York. 1999.
19. Gage FH, Eagle K, Tuszynski MH. NGF dependent regeneration of adult septal
cholinergic axons into denervated hippocampus. In: Life and Death in the Nervous System.
Ibanez C, Fuxe K, Hokfelt T, Jornvall H, Olson L, Ottoson D, ed. Proceedings of the WennerGren International Series, 1995.
20. Tuszynski MH, Gage FH. Somatic gene therapy for nervous system disease. CIBA
Foundation Symposia, 1996;196:85-97.
21. Tuszynski MH. The future of neuronal growth factors for neurological disease. Western
Journal of Medicine, in press.
22. Blesch A, Tuszynski MH. Gene therapy for neurological disorders. Clinical Neuroscience,
1996;3:268-274.
23. Tuszynski MH. Gene therapy for neurodegenerative disease. Ann NY Acad Sci,
1997;835:1-11.
24. Tuszynski MH. Gene therapy: A new strategy for the treatment of neurological disease.
The Neuroscientist, 1998; 4:398-407.
25. Conner J, Tuszynski MH. Growth factor therapy. Mental Retardation and Develop.
Disabilities Res Rvw, 1998;4:212-222.
26. Blesch A, Grill RJ, Tuszynski MH. Neurotrophin gene therapy in CNS models of trauma
and degeneration. In: Progress in Brain Research. Neuronal Degeneration and Regeneration:
From Basic Mechanisms to Prospects for Therapy. Van Leeuwen FW, Salehi A, Giger RJ,
Holtmaat AJGD, and Verhaagen J, eds. Elsevier, Amsterdam. 1998.
27. Grill R, Tuszynski MH. Axonal responses to injury. In: CNS Regeneration: Basic Science
and Clinical Applications, Tuszynski MH and Kordower JH, eds. Academic Press, San Diego.
1999. pp 27-54.
28. Tuszynski MH. Neurotrophic factors. In: CNS Regeneration: Basic Science and Clinical
Applications, Tuszynski MH and Kordower JH, eds. Academic Press, San Diego. 1999. pp 109158.
29. Kordower JH, Tuzynski MH. Fetal neuronal grafting for CNS regeneration. In: CNS
Regeneration: Basic Science and Clinical Applications, Tuszynski MH and Kordower JH, eds.
Academic Press, San Diego. 1999. pp 159-182.
30. Tuszynski MH, Gage FH, Mufson EJ, Kordower JH. Neurotrophic factors, gene therapy
and Alzheimer's disease. In: CNS Regeneration: Basic Science and Clinical Applications,
Tuszynski MH and Kordower JH, eds. Academic Press, San Diego. 1999. pp 505-528.
31. Tuszynski MH, Grill R, Blesch A. Spinal cord regeneration. In: CNS Regeneration: Basic
Science and Clinical Applications, Tuszynski MH and Kordower JH, eds. Academic Press, San
Diego. 1999. pp 605-630.
16
32. Grundman M, Tuszynski MH. Designing clinical trials for neural repair. In: CNS
Regeneration: Basic Science and Clinical Applications, Tuszynski MH and Kordower JH, eds.
Academic Press, San Diego. 1999. pp 647-662.
33. Conner JM, Tuszynski MH. The relationship of lesion-induced damage to central
cholinergic systems to Alzheimer's disease: lessons from NGF studies. In: Innovative Animal
Models of Central Nervous System Diseases: From Molecule to Therapy edited by D.F.
Emerich, R.L. Dean III and P.R. Sandberg, Totowa: Humana Press, 2002.
34. Blesch A, Tuszynski MH. Ex vivo gene therapy in the CNS. Handbook Exper Pharm,
2002: Springer, Berlin.
35. Lacroix S, Tuszynski MH. Responses of injured spinal cord axons to grafts of cells
genetically modified to produce trophic factors. In: Neurorehabilitation and Neural Repair,
Selzer ME, ed. 2000;14:265-75.
36. Lu P, Tuszynski MH. Stem cells for spinal cord injury. In: Neural Stem Cells for Brain
and Spinal Cord Repair. 2002. Zigova T, Snyder EY and Sanberg PR, eds. Humana Press,
Totowa, NJ.
37. Blesch A, Tuszynski MH. Neurotrophic factors and gene therapy in spinal cord injury.
Topics in Spinal Cord Injury Rehab, 2000; 6:42-51.
38. Tuszynski MH. Ex vivo NGF gene therapy for Alzheimer’s disease. In: Proceedings of
the First Annual Institute for the Study of Aging Alzheimer’s Symposium. Spring-Verlaag, 2000.
39. Blesch A, Lu P, Tuszynski MH. Neurotrophic factors, gene therapy and neural stem cells
for spinal cord repair. Brain Res Bull, 2002; 57:833-838.
40. Weidner N, Tuszynski MH. News & Views: Spontaneous plasticity in the injured spinal
cord – implications for repair strategies. Molecular Psychiatry, 2002;7:9-11.
41. Blesch A, Tuszynski MH. Spontaneous and neurotrophin-induced axonal plasticity after
spinal cord injury. Prog Brain Res, 2002;137:413-421.
42. Jones LL, Oudega M, Bunge MB, Tuszynski MH. Neurotrophic factors, cellular bridges
and gene therapy for spinal cord injury. J Physiol, 2001;533:83-89.
43. Merrill DA, Blesch A, Tuszynski MH. Therapeutic potential of nervous system growth
factors for neurodegenerative disease. Exp Therapeutics, 2002; 2:89-96.
44. Tuszynski MH, Conner JM, Blesch A, Smith D, Merrill DA, Vahlsing HL. New strategies in
neural repair. Prog Brain Res, 2002; 138:401-420.
45. Tuszynski MH. Gene therapy for neurodegenerative disorders. The Lancet Neurology,
2002; 1:51-57.
46. Blesch A, Tuszynski MH (2002). Ex vivo gene therapy in the CNS. In: Marcoux FW, Choi
DW (eds.) CNS Neuroprotection (Handbook of Experimental Pharmacology Vol. 155). pp.
301-324
17
47. Tuszynski MH, Thal L, U HS, Pay MM, Blesch A, Conner J, Vahlsing HL. Nerve growth
factor gene therapy for Alzheimer's disease. J Mol Neurosci. 2002;19:207.
48. Tuszynski MH, U HS, Alksne J, Bakay RA, Pay MM, Merrill DA, Thal LJ. Growth factor
gene therapy for Alzheimer’s disease. Neurosurgical Focus, 2002l 13:e5.
49. Tuszynski MH. Gene therapy for neurological disease. Expert Opin. Biological Therapy.
2003;3:815-828.
50. Tuszynski MH. Neurotrophic factors for Alzheimer’s disease. In: Current Clinical
Neurology, Alzheimer’s Disease: A Physician’s Guide to Practical Management, Richter RW
and Richeter BZ, ed. 2003, Humana Press Inc., Totowa, N.J.
51. Tuszynski MH, Blesch A. Nerve growth factor: From animal models of cholinergic
neuronal degeneration to gene therapy in Alzheimer’s disease. In: Progress in Brain
Research. Aloe E, ed. Elsevier, 2003; 146:441-449.
52. Tuszynski MH. Prospects for Gene Therapy for CNS Disease. In: Neuroscience,
Molecular Medicine and the Therapeutic Transformation of Neurology. Waxman S, ed. Elsevier
Press, San Diego, 2004.
53. Blesch A, Tuszynski MH. Nucleus hears axon’s pain. Nature Med, 2004;10:236-237.
54. Nagahara A, Tuszynski MH. The ageless question: what accounts for age-related
cognitive decline? Science SAGE KE, 2004:pe20
55. Imitola J, Park KI, Teng YD, Nisim S, Lachyankar M, Ourednik J, Mueller FJ, Yiou R, Atala
A, Sidman RL, Tuszynski M, Khoury SJ, Snyder EY. Stem cells: cross-talk and
developmental programs. Philos Trans R Soc Lond B Biol Sci 2004;359:823-837.
56. Lu P, Tuszynski MH. Can bone marrow-derived stem cells differentiate into functional
neurons? Exp Neurol, 2005;193:273-278.
57. Tuszynski MH. New strategies for CNS repair. LE-TeX. In: Schering Foundation
Workshop 53 - Opportunities and Challenges of the Therapies Targeting CNS Regeneration.
Springer-Verlag, 2005; 53:1-10.
58. Blight A, Tuszynski MH. Clinical trials in spinal cord injury. J Neurotrauma. 2006; 23:586593.
59. Bartus RT, Herzog CD, Bishop K, Ostrove JM, Tuszynski M, Kordower JH, Gasmi M.
Issues regarding gene therapy products for Parkinson's disease: the development of CERE-120
(AAV-NTN) as one reference point. Parkinsonism Relat Disord. 2007;13 Suppl 3:S469-77.
60. Conner JM, Tuszynski MH. Neurotrophins: physiology and pharmacology. Encyclopedia
of Neuroscience. Elsevier, San Diego. 2007.
61. Blesch A, Tuszynski MH. Neurotrophic factor therapy: NGF, BDNF and NT-3.
Encyclopedia of Neuroscience. Elsevier, San Diego. 2007.
18
62. von dem Bussche M, Tuszynski MH. Growth Factor and Neuron Atrophy. Encyclopedia of
Neuroscience. Elsevier, San Diego. 2007.
63. Nagahara A, Tuszynski MH. Growth factors in Alzheimer’s disease. In: Alzheimer’s
Disease, eds. Sisodia A and Tanzy R. Elsevier, San Diego. 2007.
64. Tuszynski MH. Nerve growth factor gene delivery: Animal models to clinical trials. Dev
Neurobiol 2007; 67: 1204-1215.
65. Tuszynski MH. Nerve growth factor gene therapy in Alzheimer’s disease. Alzheimer’s
Disease and Associated Disorders. 2007; 21:179-189.
66. Blesch A, Tuszynski MH. Neurotrophic factors in Alzheimer’s disease. In: CNS
Regeneration, Ed. 2. Kordower J and Tuszynski MH, editors. Elsevier, San Diego. 2007.
67. Tuszynski MH, Lu P. Axonal plasticity and regeneration in the injured spinal cord. In: CNS
Regeneration, Ed. 2. Kordower J and Tuszynski MH, editors. Elsevier, San Diego. 2007.
68. Johnson E, Tuszynski MH. Neurotrophic factors. In: CNS Regeneration, Ed. 2. Kordower
J and Tuszynski MH, editors. Elsevier, San Diego. 2007.
69. Aiuti A, Bachoud-Lévi AC, Blesch A, Brenner MK, Cattaneo F, Chiocca EA, Gao G, High
KA, Leen AM, Lemoine NR, McNeish IA, Meneguzzi G, Peschanski M, Roncarolo MG, Strayer
DS, Tuszynski MH, Waxman DJ, Wilson JM. Progress and prospects: gene therapy clinical
trials. Gene Ther. 2007, 14:1555-1563.
70. Lu P, Tuszynski MH. Growth factors and combinatorial therapies for CNS regeneration.
Exp Neurol, 2008; 209:313-320.
71. Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H,
Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW,
Galasko D, Hyman B, Kuller L, Schenk D, Snyder S, Thomas RG, Tuszynski MH, Vellas B,
Wurtman RJ, Snyder PJ, Frank RA, Albert M, Doody R, Ferris S, Kaye J, Koo E, MorrisonBogorad M, Reisberg B, Salmon DP, Gilman S, Mohs R, Aisen PS, Breitner JC, Cummings JL,
Kawas C, Phelps C, Poirier J, Sabbagh M, Touchon J, Khachaturian AS, Bain LJ. A roadmap
for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement. 2008,
4:156-163.
72. Blesch A, Tuszynski MH. Spinal cord injury: Plasticity, regeneration and the challenge of
translational drug development. Trends in Neurosciences. 2009; 32:41-47.
73. Blight A, Curt A, Ditunno JF, Dobkin B, Ellaway P, Fawcett J, Fehlings M, Grossman RG,
Lammertse DP, Privat A, Steeves J, Tuszynski MH, Kalichman M, Guest JD. Position
statement on the sale of unproven cellular therapies for spinal cord injury: the international
campaign for cures of spinal cord injury paralysis. Spinal Cord. 2009 Sep;47(9):713-714.
75. Tuszynski MH. Community corner: Mutant mice challenged as models of injury in the
central nervous system. Nature Med, 2010, 16:860
75. Giger RJ, Hollis ER 2nd, Tuszynski MH. Guidance molecules in axon regeneration. Cold
19
Spring Harb Perspect Biol 2010, 2:a001867
76. Nagahara A, Tuszynski MH. Therapeutic use of BDNF in neurodegenerative and other
diseases. Nature Rev Drug Discov, 2011, 10:209-219.
77. Hollis ER 2nd, Tuszynski MH. Neurotrophins: potential therapeutic tools for the treatment
of spinal cord injury. Neurotherapeutics. 2011;8:694-703.
78. Nout YS, Rosenzweig ES, Brock JH, Strand SC, Moseanko R, Hawbecker S, Zdunowski S,
Nielson JL, Roy RR, Courtine G, Ferguson AR, Edgerton VR, Beattie MS, Bresnahan JC,
Tuszynski MH. Animal Models of Neurologic Disorders: A Nonhuman Primate Model of Spinal
Cord Injury. Neurotherapeutics. 2012, in press.
79. van Niekerk EA, Tuszynski MH. Spinal cord injury: Mechanisms, cellular and molecular
therapies, and human translation. Spinal Cord Injury, M Selzer, ed. 2012. Cambridge University
Press.
80. Blesch A, Fischer I, Tuszynski MH. Gene therapy, neurotrophic factors and spinal cord
regeneration. In: Handbook of Clinical Neurology: Spinal Cord Injury. Vol 109, series 3. J
Verhaagen and J McDonald III, eds. 2012. Elsevier.
81. Yoon C, Tuszynski MH. Frontiers of spinal cord and spine repair: experimental approaches
for repair of spinal cord injury. Adv Exp Med Biol. 2012;760:1-15.
82. Lu P, Kadoya K, Tuszynski MH. Axonal growth and connectivity from neural stem cell
grafts
in models of spinal cord injury. Curr Opin Neurobiol. 2014; 27C:103-109.
83. van Niekerk E, Tuszynski MH.. Spinal cord injury: mechanisms, cellular and molecular
therapies, and human translation. In: Textbook of Neural Repair and Rehabilitation. 2nd edition,
editors Selzer M, Clarke S, Cohen L, Kwakkel G, Miller R. Cambridge Univ Press, 2014.
84. Ommaya AK, Adams KM, Allman RM, Collins EG, Cooper RA, Dixon CE, Fishman PS,
Henry JA, Kardon R, Kerns RD, Kupersmith J, Lo A, Macko R, McArdle R, McGlinchey RE,
McNeil MR, O'Toole TP, Peckham PH, Tuszynski MH, Waxman SG, Wittenberg GF.
Opportunities in rehabilitation research. J Rehabil Res Dev. 2013;50:vii-xxxii. doi:
10.1682/JRRD.2012.09.0167.
85. Nagahara A, Tuszynski MH. Gene therapy for Alzheimer’s disease. In: Gene and Cell
Therapy: Therapeutic Mechanisms and Strategies, 4th edition. Chap. 52.
86. Liu C, Pyne R, Sakamoto J, Tuszynski MH, Chan C. Axonal regeneration and myelination:
Applicability of the layer-by-layer technology. In: Layer-by-layer films for biomedical
applications. Picart C, Caruso F and Voegel J-C, eds. Wiley-VCH Verlag GmbH & Co. 2015.
87. Dulin JN, Antunes-Martins A, Chandran V, Costigan M, Lerch JK, Willis DE, Tuszynski MH.
Transcriptomic Approaches to Neural Repair. J Neurosci. 2015; 35:13860-13867.
88. Molecular and Cellular Mechanisms of Axonal Regeneration After Spinal Cord Injury.
van Niekerk EA, Tuszynski MH, Lu P, Dulin JN. Mol Cell Proteomics. 2015; [Epub ahead of
print] PMID: 26695766
20
BOOKS:
Tuszynski MH, Kordower JA, eds. CNS Regeneration: Basic Science and Clinical Aspects.
Academic Press, San Diego. 1999.
Kordower JA, Tuszynski MH, eds. CNS Regeneration: Basic Science and Clinical Aspects.
2nd Edition. Elsevier, San Diego. 2007.
Tuszynski MH. Translational Neuroscience. Springer, New York. 2015
EDITOR FOR SPECIAL JOURNAL ISSUES:
Tuszynski MH, Bakay R, eds. Cell Transplantation special issue: Proceedings of the 4th
Annual American Society for Neural Transplantation. 1999.
Tuszynski MH, ed. Topics in Spinal Cord Injury Rehabilitation. 2000; 6:2.
EDITOR FOR SPECIAL JOURNAL ISSUES:
Tuszynski MH, Bakay R, eds. Cell Transplantation special issue: Proceedings of the 4th
Annual American Society for Neural Transplantation. 1999.
Tuszynski MH, ed. Topics in Spinal Cord Injury Rehabilitation. 2000; 6:2.
OTHER:
Reviewer for Science, Nature, Nature Neuroscience, Nature Medicine, Nature Reviews,
Proceedings of the National Academy of Sciences, Lancet, Cell, Neuron, Cell Stem Cell,
Journal of Neuroscience, Journal of Comparative Neurology, and others.
Grant reviewer for NIH (including Chair, FORE-SCI Study section), Medical Research Council
of the UK, Medical Research Council of Canada, the Veterans Administration, The Wellcome
Trust, The Israeli Science Foundation, The Polish Academy of Sciences, The Alzheimer’s
Association, Christopher Reeve Paralysis Association, Paralyzed Veterans of America,
Paralysis Project, National Paralysis Association, Heumann Foundation and others. Nominator
for McKnight “Genius” Awards.
21
LECTURE INVITATIONS:
2016
Annual Symposium on Regenerative Rehabilitation. “Neural Stem Cell Therapy for Spinal Cord
Injury.” October 15, 2016. Atlanta, GA.
11th International Levi-Montalcini Nerve Growth Factor Meeting. “Growth Factor Therapy in
Neurodegenerative Disorders.” April 23, 2016. Bologna, Italy.
2015
Proteomics Center, University of California – San Francisco. “Proteomics in Spinal Cord Injury
Research.” Nov 19, 2015. San Francisco, CA.
Reeve-Irvine Award, University of California – Irvine. “Repair of the Injured Spinal Cord.” Nov 5,
2015. Irvine, CA.
Cornell University Medical Center Burke Rehabilitation Institute. 50th Anniversary Symposium.
“Neural Stem Cells in Spinal Cord Injury.” October 9, 2015. White Plains, NY.
International Spinal Research Trust. “Challenges in Translation.” September 4, 2015. London,
England.
Weitzmann Institute, Benozlyo Center for Neurological Disease. “Gene and Cell Therapy for
Neurological Disorders.” June 18, 2015. Rehovot, Israel.
Wings for Life Annual Research Symposium. “Neural Stem Cells in Spinal Cord Injury.” May 6,
2016. Salzburg, Austria.
German Center for Neurodegenerative Disease. “Neural Stem Cells in Spinal Cord Injury.” May
4, 2015. Munich, Germany.
Canadian Meeting on Spinal Cord Repair. “Neural Stem Cells in Spinal Cord Injury.” April 27,
2015. Banff, Canada.
Spring Neuroplasticity Meeting. “Neural Stem Cells in Spinal Cord Injury.” March 20, 2015.
Sedona, AZ.
Salk Institute Symposium: Spinal Cord Injury. “Neural Stem Cells in Spinal Cord Injury.”
February 12, 2015. La Jolla, CA.
American Academy of Neurology Translational Neuroscience Course. “Proteinopathy in
Neurodegenerative Disorders.” Jan 23, 2015. Scottsdale, AZ.
Takeda Translational Neuroscience Symposium. “Neural Stem Cells in Spinal Cord Injury.”
January 15, 2015. Osaka, Japan.
2014
Johns Hopkins University Neuroscience Lecture Series. “Neural Stem Cells in Spinal Cord
Injury.” Nov 4, 2014. Baltimore, MD.
22
Cell Symposium in Translational Neuroscience. “Cell and Gene Therapy for Nervous System
Disorders.” Nov 13, 2014. Washington, DC.
Harvard University Neuroscience Lecture Series. “Neural Stem Cells in Spinal Cord Injury.”
October 29, 2014. Boston, MA.
UCLA Inaugural Symposium of Integrative Center for Neural Repair. ““Neural Stem Cells in
Spinal Cord Injury.” October 22-23, 2014. Los Angeles, CA.
International Neurotrauma Society. “Neural Stem Cells in Spinal Cord Injury.” Plenary Lecture.
June 30, 2014. San Francisco, CA.
TERMIS International Meeting (Bioengineering Society). “Templated Scaffolds for Neural
Regeneration.” Plenary Lecture. June 11, 2014. Genoa, Italy.
Case Western Neuroscience Lecture Series. “Neural Stem Cells in Spinal Cord Injury.” May 16,
2014. Cleveland, OH.
University of Kentucky Neuroscience Lecture Series. “Neural Stem Cells in Spinal Cord Injury.”
April 10, 2014. Lexington, KY.
International Gene Therapy Meeting. “Growth Factor Gene Therapy for Neurodegenerative
Disorders.” February 10, 2014. Cancun, Mexico.
2013
Washington University Neuroscience Lecture Series. “Neural Stem Cells in Spinal Cord Injury.”
December 10, 2013. St. Louis, MO.
Cold Spring Harbor Meeting. “Neural Stem Cells in Spinal Cord Injury.” October 22, 2013.
Shanghai, China.
American Neurological Association Jacoby Award Lecture. “Cell and Gene Therapy for Nervous
System Disorders.” October 15, 2013. New Orleans, LA.
International Spinal Research Trust. “Neural Stem Cells in Spinal Cord Injury.” September 6,
2013. London, U.K.
International Regeneration Meeting (INTR). “Growth Factor Gene Therapy for Alzheimer’s
Disease.” September 5, 2013. Wales, U.K.
Swiss Institute of Technology (EPFL). “Neural Stem Cells in Spinal Cord Injury.” August 29,
2013. Lusaunne, Switzerland.
UC Irvine Reeve Medal Ceremony. ““Neural Stem Cells in Spinal Cord Injury.” May 30, 2013.
Irvine, CA.
Keystone Symposium: Axonal Growth to the Extreme. “Neural Stem Cells in Spinal Cord Injury.”
March 13, 2013. Lake Tahoe, CA.
Adelson Medical Research Foundation. “Molecular Regulators of Axonal Regeneration.” March
12, 2013. Las Vegas, NV.
23
California Institute for Regenerative Medicine. “Neural Stem Cells in Spinal Cord Injury.” March
6, 2013. San Francisco, CA.
2012
Novartis Neuroscience Forum. “Growth Factor Gene Delivery for Neurodegenerative Disorders,
and a Retrospective on Fred Plum.” November 24, 2012. Tokyo, Japan.
The Fred Plum Memorial Symposium. “Growth Factor Gene Delivery for Neurodegenerative
Disorders, and a Retrospective on Fred Plum.” November 16, 2012. New York, NY.
Chile – United States Neuroscience Initiative. “The Neurobiology of CNS Growth Factors.”
September 25, 2012. Santiago, Chile.
International Spinal Research Trust. “Combinatorial Strategies to CNS Repair.” September 7,
2012. London, England.
California Institute of Regenerative Medicine – Ministry of Science and Technology (MOST) of
the Peoples Republic of China Joint Symposium. “Stem Cell Therapy for Spinal Cord Injury.”
June 10, 2012. Shanghai, China.
American Society for Gene Therapy. “BDNF Gene Therapy for Alzheimer’s Disease.” May 17,
2012. Philadelphia, PA.
California Institute of Regenerative Medicine. “Large Animal Models in Translational
Neuroscience Research.” April 27, 2012. San Francisco, CA.
Korean Dementia Association Meeting. “Growth Factor Gene Delivery for Neurodegenerative
Disorders.” April 23, 2012. Seoul, Korea
2011:
Asilomar Conference on Spinal Cord Injury. Plenary Lecture. “Axonal Plasticity and
Regeneration in the Injured Spinal Cord: Sprouting, Regeneration or What?” December 9,
2011. Monterey, California.
The Goldberg Lecture, University of Rochester. “Growth Factor Gene Delivery for
Neurodegenerative Disorders.” October 21, 2011. Rochester, New York.
Glaxo Smith Kline Neuroscience Lecture Series. “Growth Factor Gene Delivery for
Neurodegenerative Disorders.” August 3, 2011. Shanghai, China.
International Conference on Alzheimer’s Disease (ICAD). “BDNF Gene Delivery for Alzheimer’s
Disease.” July 18, 2011. Paris, France.
Ohio State University Neuroscience Lecture Series. “Axonal Plasticity and Regeneration in the
Injured Spinal Cord.” May 16, 2011. Columbus, Ohio.
ICord First Annual Student Symposium, University of British Columbia. Plenary Lecture. “Axonal
Plasticity and Regeneration in the Injured Spinal Cord.” May 6, 2011, Vancouver, British
Columbia, Canada.
University of Alabama Neuroscience Lecture Series. “Growth Factor Gene Therapy in Models of
24
Neurodegeneration.” April 5, 2011. Birmingham, Alabama.
Emory University Alzheimer’s Disease Lecture Series. “Growth factor gene therapy for
Alzheimer’s Disease.” February 10, 2011. Atlanta, Georgia.
Brain Awareness Symposium Lecture, St. Louis University School of Medicine. “Growth Factor
Therapy in Translational Neuroscience.” March 10, 2011. St. Louis, MO.
Winter Brain Conference. “Spontaneous Axonal Plasticity After Primate SCI” January 24, 2010.
Copper Mountain, CO. January 24, 2011.
2010:
Grand Rounds, Cornell-Weill Medical School. “Growth Factor Gene Therapy in
Neurodegenerative Disorders.” December 2, 2010. New York, NY.
Stein Institute for Research on Aging Public Lecture Series. “Growth Factor Gene Therapy for
Alzheimer’s Disease.” November 18, 2011. San Diego, CA.
Annual Cognition and Aging Conference. “Growth Factor Gene Therapy in Neurodegenerative
Disorders.” November 12, 2011. Laguna, CA.
Inaugural Keynote Lecture, Heidelberg Comprehensive Institute for Spinal Cord Injury
Research. “Combinatorial Strategies in SCI Research.” October 10, 2010. Heidelberg,
Germany.
American Society of Anesthesiology. “Growth Factor Gene Therapy in Neurodegenerative
Disorders.” October 18, 2010. San Diego, CA.
European Spinal Cord Injury Research Consortium Meeting. “Combinatorial Therapies for
SCI.” August 28, 2010. Ittingen, Switzerland.
Nature Medicine Conference on Neurodegeneration. “Growth Factor Gene Therapy in
Neurodegenerative Disorders.” May 27, 2010. Munich, Germany.
American Association of Anatomists. “Axonal Plasticity and Regeneration in the Spinal Cord.”
April 26, 2010. Anaheim, CA.
Winter Brain Conference. “Axonal Plasticity and Regeneration in the Spinal Cord.” January 28,
2010. Breckenridge, CO.
2009:
Gordon Conference on Growth Factors. “Neuroprotective Effects of BDNF in Animal Models of
Alzheimer’s Disease.” June 25, 2009, Newport, Rhode Island.
American Association of Neurosurgery. “Growth Factor Gene Therapy for Neurodegenerative
Disorders”. April 30, 2009, San Diego, CA.
Society for Neuroscience, San Diego Chapter Inaugural Seminar Series. “Growth Factor Gene
Therapy for Neurodegenerative Disorders”. April 23, 2009, San Diego, CA.
25
Center for National Research, Rome: 100th Birthday Seminar for Rita Levi-Montalcini. “Nerve
Growth Factor Gene Delivery for Alzheimer’s Disease”. April 21, 2009, Rome, Italy.
Johns Hopkins University Neurology Grand Rounds. “Growth Factor Gene Therapy for
Neurodegenerative Disorders”. March 26, 2009, Baltimore, MD.
Keystone Meeting. “Combinatorial Approaches to Spinal Cord Injury.” February 20, 2009.
Colorado.
Winter Conference in Brain Plasticity. ““Combinatorial Approaches to Spinal Cord Injury.”
January 29, 2009. Utah.
2008:
Larry Ruvo Alzheimer’s Association Meeting. “Growth Factor Therapy for Alzheimer’s Disease.”
Dec 8, 2009, Las Vegas, NV
Indian Government Commission on Biotechnology. “Strategies in Neural Repair.” Dec 3, 2008.
Mumbai, India.
International Spinal Research Trust. “Combinatorial Therapies for Chronic Spinal Cord Injury,”
September 6, 2008. London, England.
International Conference on Alzheimer’s Disease. “Growth Factor Gene Delivery for Alzheimer’s
Disease.” July 30, 2008, Chicago, IL.
Sell Lectureship, American Spinal Injury Association. “Spinal Cord Regeneration.” June 22,
2008. San Diego, CA.
Plenary Lecture, Japanese Geriatric Society. “Nerve Growth Factor Gene Therapy for
Alzheimer’s Disease.” June 20, 2008. Tokyo, Japan.
American Society for Gene Therapy. “Nerve Growth Factor Gene Therapy for Alzheimer’s
Disease.” June 1, 2008. Boston, Mass.
Frontiers of Neuroscience Symposium, American Academy of Neurology Annual Meeting.
“Plasticity and Regeneration in the Injured Spinal Cord.” April 18, 2008. Chicago, IL.
National Yan-Ming University / UCSD Joint Symposium in Bioengineering. “Bioengineered
Guidance Scaffolds for Spinal Cord Injury.” April 10, 2008, University of California- San Diego.
Yale University Neuroscience Biomedical Engineering Lecture Series. “Plasticity and
Regeneration in the Injured Spinal Cord.” April 4, 2008.
Lois Pope Lecture Series, Miami Project to Cure Paralysis. “Combinatorial Therapies for Spinal
Cord Injury.” April 3, 2007. Miami, FL.
Keystone Symposium. “Growth Factors in Neurodegenerative Disorders.” Keystone, Co.
March 26, 2008.
Health and Wellness Lecture Series. “Growth Factor Gene Therapy for Neurodegenerative
Disorders.” March 19, 2008. University of California- San Diego.
26
Life, Death and the Renewal of the Neuron: The Leap From Bench to Bedside. Washington
University in St. Louis. “Growth Factor Gene Therapy for Neurodegenerative Disorders.”
February 29, 2008. St. Louis, MO.
Keynote Address, New York Academy of Sciences Symposium on Spinal Cord Injury Research.
“Bridging Axonal Regeneration in SCI.” January 16, 2008. New York, NY.
Grand Rounds, Mt. Sinai University Medical School, Dept. of Neurology. “Plasticity and
Regeneration in the Injured Spinal Cord.” January 14, 2008. New York, NY.
2007:
Ruvo Brain Institute. “Growth Factor Gene Therapy for Alzheimer’s Disease.” December 3,
2007. Las Vegas, NV.
National Institutes of Health, Conference on Gene Therapy. “Gene Therapy for Alzheimer’s
Disease.” November 13, 2007. Bethesda, Maryland.
Adelson Biomedical Research Foundation Symposium. “Growth Factor Influences on Axonal
Plasticty and Regeneration in the Adult CNS.” September 18, 2007. Boston, MA.
Parkinson’s Disease Foundation. “Growth Factor Therapy for Parkinson’s Disease.”
September 13, 2007. San Diego, CA.
European Spinal Cord Injury Research Consortium Meeting. “Combinatorial Therapies for
SCI.” Sept 7, 2007. Zurich, Switzerland.
Reeve-Irvine Spinal Cord Injury Course. “Growth Factors in Models of Spinal Cord Injury.” July
11, 2007. Irvine, CA.
13th annual Kentucky Spinal Cord and Head Injury Research Trust Symposium. “Translational
Clinical Trials in Spinal Cord Injury.” June 7, 2007. Louisville, KY.
Department of Internal Medicine, Program In Medical Research Series. “Gene Therapy for
Neurodegenerative Disease.” May 21, 2007. UCSD Medical Center, San Diego, CA.
American Academy of Neurology Annual Meeting. “Neuroprotective Strategies for Alzheimer’s
Disease.” April 30, 2007. Boston, MA.
Alzheimer’s Disease Research Center Conference on Alzheimer’s Disease Research and
Therapy. “NGF Gene Transfer for Alzheimer’s Disease.” April 10, 2007, U.S. Grant Hotel, San
Diego, CA.
California Roman Reed Spinal Cord Injury Conference. “Primate Models of Neural Plasticity.”
March 16, 2007, University of California – Irvine, Irvine, CA
Reeve-Irvine Medal Symposium. “Combinatorial Strategies in Neuroregeneration Research.”
March 15, 2007, Irvine, CA
Neural Plasticity Conference, Adelson Program in Neural Repair. “Axonal Plasticity and
Regeneration in the CNS.” March 10, 2007, Las Vegas, NV.
27
Winter Brain Conference. “Experience-Dependent Cortical Motor System Plasticity.” February
2, 2007. Snowmass, CO.
2006:
Asia Pacific Conference on Neural Regeneration, plenary lecture. “Spinal Cord Plasticity and
Regeneration.” Dec 4, 2006. Shanghai, China.
Neurology Grant Rounds, University of South Carolina. “Growth Factor Gene Delivery for
Neurodegenerative Disorders.” November 4, 2006. Charleston, SC.
Canadian Alzheimer’s Association, Plenary Lecture. “Growth Factor Gene Therapy for
Alzheimer’s Disease.” November 8, 2006. Toronto, Canada.
11th International Alzheimer’s Disease Meeting. “Growth Factor Gene Therapy for Alzheimer’s
Disease.” July 18, 2006. Madrid, Spain.
Swammerdam Lecture, Amsterdam Graduate School of Neurosciences. “Growth Factor
Modulation of Cell Growth and Survival in the CNS.” June 15, 2006. Amsterdam, The
Netherlands.
American Society of Gene Therapy. “Gene Therapy for Alzheimer’s Disease.” June 3, 2006.
Boston, MA.
9th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. “Growth
Factor Gene Therapy for Alzheimer’s Disease.” April 20, 2006. Geneva, Switzerland.
Berlex Pharmaceuticals. “Growth Factor Gene Delivery for Neurodegenerative Disorders.”
April 5, 2006. San Francisco, CA.
Annual Meeting, American Academy of Neurology course on Neural Repair. “Growth Factors in
Clinical Trials: Ethical Aspects.” April 4, 2006. San Diego, CA.
Roman Reed Spinal Cord Injury Research Meeting. “Clinical Trials in Spinal Cord Injury.”
March 8, 2006. University of California - Irvine, Irvine, CA.
Roman Reed Spinal Cord Injury Research Meeting. “Neural Transplantation for Spinal Cord
Injury.” March 8, 2006. University of California - Irvine, Irvine, CA.
International Campaign to Cure Paralysis SCI Seminar: “Translational Trials in SCI.” Feb 15,
2006. Ontario, Canada.
4th International Gene Therapy Symposium. “Growth Factor Gene Therapy for Alzheimer’s
Disease.” Feb 4, 2006. Osaka, Japan.
UCSD Department of Pharmacology Seminar Series. “Trophic Modulation of Neuronal Function
and Survival in the Adult CNS.” Jan 17, 2006.
2005:
Neural Restoration Symposium. “Growth Factor Gene Therapy for Neurological Disease.”
December 12, 2005. Las Vegas, Nevada.
28
Network of European CNS Transplantation And Restoration Annual Meeting. “Growth Factor
Gene Therapy for Alzheimer’s Disease.” December 8, 2005. Amsterdam, The Netherlands.
Symposium on Mechanisms Regulating Network Organization and Function in the Spinal Cord:
“Growth Factor-Induced Plasticity in the Spinal Cord.” Nov 17, 2005. University of Wisconsin
Medical School.
Annual Meeting on Neurodegeneration and Neuroprotection in Multiple Sclerosis. “Growth
Factor Gene Delivery for Neurological Disorders.” Oct 21, 2005. Charleston, South Carolina.
ICORD International Advisory Panel Symposium, University of British Columbia. “Combinatorial
Approaches to Spinal Cord Regeneration.” October 17, 2005. Vancouver, Canada.
10th Congress of the International Association of Biomedical Gerontology (IABG). “Growth
Factor Modulation of Age-Related Neuronal Degeneration.” Cambridge University, U.K. Sept
9, 2005.
American Paraplegia Society Annual Meeting. “Strategies to Enhance Motor Recovery after
SCI.”Sept 7, 2005. Las Vegas, Nevada.
International Spinal Research Trust Meeting. “Translational Trials in Spinal Cord Injury.” Sept
3, 2005. London, England.
International Campaign to Cure Paralysis SCI Seminar: “Enrollment Criteria in Clinical Trials of
SCI.” Sept 2, 2006. London, England.
Gordon Conference on Neurotrophic Factors. “Growth Factor Gene Therapy for Alzheimer’s
Disease.” June 20, 2005. Newport, Rhode Island.
Keynote Address, 9th International Conference on Neural Transplantation and Repair. “Growth
Factor Gene Therapy for Alzheimer’s Disease.” International Society for Neural Repair. June
10, 2005. Taipei, Taiwan.
American Society of Gene Therapy, Breaking Events Lecture. “A Phase I Clinical Trial of NGF
Gene Therapy.” June 3, 2005. St. Louis, Missouri.
3rd International Mickeln Symposium on Neurodegeneration and Repair. “Combinatorial
Therapies for Spinal Cord Injury.” May 21, 2005. Düsseldorf, Germany.
Industry/Academia Lecture Series. “Gene Therapy for Neurological Disease.” Kiwanis
Club/Paralyzed Veterans of America. May 4, 2005. San Diego, CA.
Public Lecture Series. “Growth Factor Gene Therapy for Alzheimer’s Disease.” Stein Institute
for Research on Aging. April 18, 2005. La Jolla, CA
American Academy of Neurology Course, Clinical Trials in Neural Repair. “Ex Vivo NGF Gene
Therapy for Alzheimer’s Disease.” American Academy of Neurology Annual Meeting, Florida.
April 14, 2005.
Gene Therapy Stakeholder’s Meeting. “Gene Therapy for Neurological Disease.” NIH/Pharma
sponsored meeting. Washington, DC. April 7, 2005.
29
Faculty Lecture Series. “Growth Factor Gene Therapy for CNS Disease.” Medical Scientist
Training Program, UCSD. April 4, 2005. La Jolla, CA.
Conference on Physiological Repair, the Pasteur Institute. “Gene Therapy for Alzheimer’s
Disease.” March 17, 2005. Paris, France.
Roman Reed Annual Meeting. “UC Consortium to Study Primate Spinal Cord Regeneration.”
March 10, 2005. Irvine, CA.
The Salk Institute Adler Symposium. “Growth Factor Gene Therapy for Alzheimer’s Disease.”
February 8, 2005. La Jolla, CA.
Arizona State University Model Systems Strategic Research Network. Stem Cells for Neural
Repair. Arizona State University, Phoenix, Arizona. February 4, 2005.
2004:
2nd International Winter-Conference on Alzheimer's Disease. “Growth Factor Gene Therapy
for Alzheimer’s Disease.” December 12, 2004. Zürs, Austria
Johns Hopkins Annual Conference on Multiple Sclerosis. “Axonal Regeneration in the Spinal
Cord.” December 4, 2004. Baltimore, MD.
UCSD Department of Bioengineering Seminar Series: “Bioengineered scaffolds for axonal
regeneration after spinal cord injury”. November 12, 2004. La Jolla, CA.
Seminar Series, Los Angeles Children’s Hospital. “Gene Therapy for Neurological Disease.”
Oct 19, 2004. Los Angeles, CA.
Grass Traveling Neuroscientist Seminar Series, Ohio State University. “Plasticity and
Regeneration in the Adult CNS”. Sept 30, 2004. Ohio State University.
International Spinal Research Trust Annual Meeting. “Growth Factor Gene Delivery Promotes
Bridging Axonal Regeneration Beyond Sites of SCI.” Sept 3, 2004. London, UK.
Vice-Chancellor’s Seminar Series. “Gene Therapy for Alzheimer’s Disease.” Aug 18, 2004.
La Jolla, CA. University of California-San Diego.
Distinguished Lecturer, Reeve-Irvine Spinal Cord Injury Annual Course, University CaliforniaIrvine. “Growth Factor Gene Therapy for Spinal Cord Injury.” July 16, 2004. Irvine, CA.
Keynote Speaker, Berlex/Schoering Neuroscience Day. “Growth Factor Gene Therapy for
Neurological Disorders”. June 16, 2004. Napa, CA.
National Academy of Sciences Review of Spinal Cord Injury Regeneration Research. “Growth
Factors for Spinal Cord Injury.” May 24, 2004. Washington, DC.
Department of Neurosurgery Grand Rounds, University of California, San Diego. “Gene
Therapy for Neurodegenerative Disorders”. May 20, 2004. San Diego, CA.
30
Annual Neuroscience Day, Keynote Speaker and Grass Traveling Lecturer, University of
Louisville. “Gene Delivery for Neurological Disorders: From Basic Mechanisms to the Clinic.”
April 22, 2003. Louisville, KY.
Roman-Reed California State Spinal Cord Injury Seminar. “Primate Models of SCI.” March 18,
2004. Irvine, CA.
Seoul University Neuroscience Symposium. “Gene Therapy for Alzheimer’s Disease.” March
11, 2004. Seoul, Korea.
Keynote Speaker, Annual Neuroregeneration Research Symposium. “Growth Factor Gene
Delivery in Models of CNS Degeneration.” Feb 26, 2003. Havana, Cuba.
Spinal International Translational Consortium First Annual Meeting. “Translational Studies of
SCI.” February 20, 2004. Vancouver, BC.
Swiss Federal Institute of Technology Verbier Meeting on Molecular, Cellular and Clinical
Aspects of CNS Injury. “Growth Factor Gene Therapy in the CNS.” January 27, 2004. Verbier,
Switzerland.
2003:
Asilomar Conference on Spinal Cord Injury. “Growth Factor Gene Delivery for SCI.” December
11, 2003. Asilomar, CA.
Scripps Research Ethics Lecture Series. “Growth Factor Gene Therapy for Neurodegenerative
Disorders.” Scripps Research Institute, November 20, 2003. San Diego, CA.
UCSD Grand Rounds. “Spinal cord Regeneration.” October 2, 2003. San Diego, CA.
Burnham Institute Symposium on Neurodegeneration. “Growth Factor Gene Therapy for
Alzheimer’s disease.” Burnham Institute, October 2, 2003. San Diego.
International Spinal Research Trust Annual Meeting. “Translational Research in SCI.”
September 19, 2003. London, England.
University of California Annual Neurotrauma Symposium. “Growth Factors for CNS Repair.”
August 21, 2003, San Diego, CA.
Distinguished Lecturer, Reeve-Irvine Annual Course on Spinal Cord Injury. “Models of Spinal
Cord Injury.” July 24, 2003. University of California – Irvine, Irvine, CA.
American Society of Gene Therapy. “Gene Therapy for Alzheimer’s Disease.” June 6, 2003,
Washington, DC.
University of British Columbia, Neuroscience Lecture Series. “Growth Factor Modulation of
CNS Plasticity and Function.” May 30, 2003. Vancouver, Canada.
Cajal Club Presidential Symposium: Neurobiology of Rehabilitation. Experimental Biology
(FASEB) Meeting. “Gene Therapy for Spinal Cord Injury.” April 13, 2003. San Diego, CA.
31
Japan Neuroregeneration Research Symposium. “Neurotrophic Factors and Gene Therapy in
Spinal Cord Injury.” March 28, 2003. Okazaki, Japan.
Scripps Research Foundation Neuroscience Lecture Series. “Growth Factor Modulation of
Plasticity in the Intact and Injured CNS.” March 26, 2003. La Jolla, CA.
Stanford Brain Research Institute Seminar Series. “Degeneration and Regeneration in the
Adult CNS.” March 6, 2003. Palo Alto, CA.
California Roman-Reed Spinal Cord Injury Symposium. “Primate Models of SCI.” Feb 25,
2003. University of California – Irvine, Irvine, CA.
StandUp Symposium on Spinal Cord Injury Regeneration. “Growth Factors in SCI.” Feb 28,
2003. La Jolla, CA.
Adler Symposium on Alzheimer’s Disease. “Neuritic Sprouting.” Feb 11 – 12, 2003. Salk
Insitute, La Jolla, CA.
NIH Spinal Cord Injury Symposium: Future Directions in SCI Research. Feb 3 – 4, 2003.
Bethesda, MD.
Winter Brain Conference, Snowbird, UT. “Gene Therapy for Alzheimer’s Disease.” Jan 29,
2003.
Verbier Neuroscience Meeting, “Molecular, cellular and clinical aspects of neurodegenerative
diseases.” Jan 19-23, 2003. Verbier, Switzerland.
2002:
Scripps Research Institute, Society of Fellows. Keynote Speaker: “Axonal Regeneration in the
Adult CNS: Balancing Inhibition With Growth”. La Jolla, CA. October 25, 2002.
UCSD Meet the Dean Lecture Series. “Gene Therapy for Alzheimer’s Disease.” October 9,
2002.
International Spinal Research Trust Research Meeting. “Regulated Gene Expression in Spinal
Cord Injury.” London, England. September 6, 2002.
Amyotrophic Lateral Sclerosis Research Symposium. “Gene Therapy for Neurological
Disorders.” Cambridge, England. July 25, 2002.
University of British Columbia Conference on Stem Cells in the Nervous System. “Stem Cells in
Spinal Cord Injury.” June 5, 2002.
International Levi-Montalcini Symposium on Nerve Growth Factor. “NGF Gene Therapy.”
Moderna, Italy, May 15, 2002.
American Academy of Neurology Course: Future of Spinal Cord Injury: Therapy Based on
Neural Repair and Gait Retraining. “Gene therapy for Spinal Cord Injury.” May, 2002.
8th Springfield/ Geneva Meeting on Advances in Alzheimer’s Disease. “Growth Factor Gene
Therapy for Alzheimer’s Disease.” Geneva, Switzerland, April 2002.
32
Reeve-Irvine Spinal Cord Regeneration Research Annual Meeting. “Primate Models of Spinal
Cord Injury.” Irvine, CA March 20, 2002.
The Sam Hersch Cerebral Palsy Symposium. “CNS Growth Factors.” Salk Institute, San
Diego. Feb. 26 - 27, 2002.
The Adler Symposium on Alzheimer’s Disease. “Neurotrophin Gene Therapy for Alzheimer’s
Disease.” Salk Institute, San Diego. Jan 28 – 30, 2002.
Winter Brain Plasticity Meeting. “NGF Gene Therapy for Alzheimer’s Disease”. Aspen, CO
January 30, 2002.
Annual meeting of the Society of Physical Regulation in Biology and Medicine. “Axonal
Regeneration After Spinal Cord Injury.” San Diego, Jan 28, 2002.
Annual Meeting of the American Peripheral Nerve Society. “Growth Factors in Neural Repair.”
Cancun, January 12, 2002.
2001:
Department of Medicine Grand Rounds, UCSD: “Gene Therapy for Alzheimer’s Disease.” San
Diego, November 21, 2001.
Biocom Seminar: "Gene Therapy for Alzheimer's Disease." San Diego, November 14, 2001.
Stein Institute for Research on Aging, public lecture at UCSD. “Gene Therapy for Alzheimer’s
Disease”. San Diego, November 21, 2001.
Society for Neuroscience Annual Meeting: "Reconnecting the spinal cord: How close are we
really?" San Diego, November 13, 2001.
Satellite Symposium to Society for Neuroscience Annual Meeting: Stem Cells. “Cellular and
Stem Gene Therapy in the CNS.” San Diego, November 10, 2001.
European Society for Gene Therapy. “Gene Therapy for Neurological Disorders.” Antalya,
Turkey. Nov 2, 2001.
American Association of Physical Medicine and Rehabilitation: “New Therapies for Spinal Cord
Injury.” October, 2001.
Congress of Neurological Surgeons: “Novel Gene-Based Strategies for Treatment of Human
Disease.” San Diego, CA. October 3, 2001.
Michael J. Fox Foundation Parkinson’s Disease Foundation. “Gene therapy for Parkinson’s
Disease”. Chicago IL. September 30, 2001.
Harvard Medical School Symposium on Gene Therapy in the Nervous System. “Ex Vivo Gene
Therapy for Alzheimer’s Disease.” Boston, MA. September 20-23, 2001.
International Spinal Research Trust Annual Symposium on Spinal Cord Injury. “Spontaneous
Plasticity in the Injured Adult Spinal Cord.” London, England. September 14-15, 2001.
33
Rick Hansen Institute Spinal Cord Injury Leaders Forum for Developing Strategic Initiatives
Worldwide. “Gene Therapy for Spinal Cord Injury.” September, 2001.
“Distinguished Lecturer”, Spinal Cord Injury Techniques Course. “Neurotrophic Factors and
Gene Therapy in Spinal Cord Injury.” University California – Irvine. July 18, 2001.
The Netherlands Academy of Neuroscience Summer Course. “Gene Therapy in the CNS.”
Amsterdam. August 22, 2001.
Kentucky Collaborative Symposium on Spinal Cord Injury. “Neurotrophic Factor Gene Therapy
for Spinal Cord Injury.” Lexington, KY. June 14-15, 2001.
UCSF Neuroscience Spring Symposium. “Axon Guidance After Adult CNS Injury.” San
Francisco, June 7, 2001.
American Society of Gene Therapy. “Nerve Growth Factor Gene Therapy for Alzheimer’s
Disease.” Seattle, WA. May 30 – June 3, 2001.
Medical Research Council of Canada and Quebec Neuroscience Society Symposium on Spinal
Cord Injury: “Neurotrophic Factor Gene Therapy for Spinal Cord Injury.” Montreal, Canada.
May 8, 2001.
American Academy of Neurology: Workshop on Therapeutic Approached to Spinal Cord Injury.
May 7, 2001
Washington Science Writer’s Seminar on Neuroregeneration Research. “Gene Therapy for
CNS Repair.” Zaven Khachaturian & Teresa Radebaugh, organizers. Washington, DC. May
12, 2001.
Conference on Alzheimer’s Disease: Translating Research into Practice. Sponsored by
Alzheimer’s Disease Research Center, UCSD. “Gene Therapy for Alzheimer’s Disease.” San
Diego, April 29, 2001.
The Hartford Foundation: Directions in Neurology and Psychiatry in the 21st Century. “Gene
Therapy for Nervous System Disease.” St. John, U.S. Virgin Islands. Mar 29, 2001.
University of California, Davis, Primate Research Symposium: “Gene Therapy for Neurological
Disease.” Davis, CA. March 2001.
Institute for Advanced Studies, Valencia, Spain: The Impact of Stem Cell Research on Neural
Transplantation. Valencia, Spain. Mar 8, 2001.
Institute for the Study of Aging. Director’s Lecture: “Gene Therapy for Alzheimer’s Disase.”
New York, NY. Feb 12, 2001
Presidential Symposium, Association for Research in Otolaryngology Annual Meeting: Aging
and Gene Therapy in the Brain. St. Petersberg, FL. Feb 4, 2001.
2000:
34
University of British Columbia, Neuroscience Lecture Series. “Neurotrophin-Mediated Neuronal
Plasticity in the Spinal Cord.” Vancouver, Canada. Dec 7, 2000.
Dana Carvey Symposium on Spinal Cord Injury. “Regeneration after Spinal Cord Injury.”
Chicago, IL. Nov 30, 2000.
Scripps Research Institute: Developing Research Ethics for Responsible Conduct in Research:
Gene Therapy. November 29, 2000.
Alzheimer’s Association. Symposium on Alzheimer’s Disease. “Gene Therapy for Alzheimer’s
Disease.” San Diego, CA. Nov 10, 2000.
Spinal Cord Injury Symposium, Society for Neuroscience Satellite Symposium. “Induced and
Spontaneous Plasticity After Spinal Cord Injury.” New Orleans, LA. Nov 4, 2000.
Neurotrauma Association: Conference on Spinal Cord Injury. “Neurotrophic Factors and Gene
Therapy for Alzheimer’s Disease.” New Orleans, LA. Nov 3, 2000.
National Institutes of Health: NINDS symposium on gene therapy. Panelist and speaker.
Washington, DC. Oct. 23-24, 2000.
Institute for the Study of Aging Research Symposium. “Gene Therapy for Alzheimer’s
Disease.” Tarrytown, NY. Oct 30-31, 2000.
San Diego State University. Gene Therapy course lecture. “Gene Therapy in the Central
Nervous System.” Sept 20, 2000.
The John Douglas French Alzheimer’s Foundation workshop: Of Mice and Men. Los Angeles,
CA. May 13, 2000. “Primates and Growth Factors.”
Society of Biological Psychiatry Annual Meeting, Symposium of Frontal Lobe Dementias,
Chicago. May 12, 2000. “Therapeutic Approaches to Degenerative Disorders: Gene Therapy.”
Neuroscience Lecture Series, Case Western Reserve University, Ohio. Apr 26, 2000.
“Neurotrophic Factors and the Extracellular Mileu in the Injured CNS”
Neuroscience Lecture Series, The Chicago Medical School. April 18, 1999. “Neurotrophic
Factors and the Extracellular Matrix in Models of Spinal Cord Injury.”
Neuronal Plasticity Conference, Kananaskis, Alberta, Canada. “Neuronal Plasticity and Growth
Factors.” March 20-23rd 2000.
Spinal Cord Injury Conference, Irvine, California. March 23, 2000. “Neurotrophic Factor Gene
Therapy for Spinal Cord Injury.”
Neuroscience Lecture Series, The Chicago Medical School. March 14, 2000. “Gene Therapy
and Neurotrophic Factors in Models of Neurodegenerative Disorders.”
University of Texas, Grand Rounds Presentation, Spring 2000. “Gene Therapy for Spinal Cord
Injury.”
35
Cell Biology Seminar, Emory University, Atlanta. “Neurotrophin Effects in the Injured Adult
CNS.” Spring 2000.
Winter Brain Conference, Breckenridge, CO., January 2000. “Gene Therapy in the CNS”.
36